Acelity Holdings

General Information
Business:

Acelity is a leading global medical technology company. We are global pioneers in advanced wound care and soft tissue repair, creating and growing new markets based on our ability to identify and address unmet clinical needs with products that advance the practice of medicine, beginning with our introduction of groundbreaking NPWT and acellular tissue matrices nearly 20 years ago. We offer a broad range of products that can be used across clinical applications, care settings and clinician groups to accelerate soft tissue healing, improve clinical outcomes and reduce overall costs of care. Our product offerings are backed by an extensive body of scientific, clinical and economic outcomes data that demonstrate the clinical efficacy and value proposition of our products.

Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees: 5700
Founded: 2015
Contact Information
Address 12930 West Interstate 10, San Antonio, Texas 78249, US
Phone Number (210) 524-9000
Web Address http://www.acelity.com
View Prospectus: Acelity Holdings
Financial Information
Market Cap
Revenues $1870.2 mil (last 12 months)
Net Income $-53.5 mil (last 12 months)
IPO Profile
Symbol TBA
Exchange NYSE
Shares (millions): 0.0
Price range $0.00 - $0.00
Est. $ Volume $1000.0 mil
Manager / Joint Managers J.P. Morgan/ Goldman Sachs/ BofA Merrill Lynch
CO-Managers Morgan Stanley/ Barclays/ Credit Suisse/ RBC Capital Markets/ UBS Investment Bank
Expected To Trade:
Status: Withdrawn
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change